Skip to main content

Branded

  • Rx-360 launches redesigned website
    WASHINGTON — International pharmaceutical supply chain consortium Rx-360 on Thursday announced the launch of a new website at its annual Rx-360 Conference in Gaylord National Harbor in Maryland. The consortium said the redesign is part of its digital evolution to showcase its industry expertise and support its overall growth. 
     

  • HDA releases 2 pilot studies in advance of Drug Supply Chain Security Act implementation

    ARLINGTON, Va. — The Healthcare Distribution Alliance  on Thursday presented two viable scenarios out of its Pilot Study for Saleable Returns, a study designed to help pharmaceutical manufacturers and distributors comply with requirements set forth by the Drug Supply Chain Security Act.

  • Report: Trump victory could boost pharmaceutical stocks

  • Novartis' Heart Partner app integrated into Walgreens Balance Rewards

    DEERFIELD, Ill. - Walgreens on Monday announced the integration of Novartis' Heart Partner app to its Balance Rewards for Health Choices API.

    "For [heart failure] patients it is sometimes difficult to keep up with a healthier lifestyle and managing their treatment," Walgreens developer evangelist Drew Schweinfurth posted in a blog. "The newly developed Heart Partner app helps coordinate care in a simple and easy way.  The app allows for tracking daily activity and vitals such as blood pressure or weight [and] medication compliance."

  • FDA approves Propeller platform for use with GSK’s Ellipta
     MADISON, Wis. — The Food and Drug Administration has cleared Propeller Health’s Propeller platform — a leading digital solution for respiratory medicine — to be used with GSK’s Ellipta, its dry powder inhaler. 
     

  • Jean Coutu Group continues flu awareness campaign

  • Female Health Company completes Aspen Park merger, rebrands as Veru Healthcare

    CHICAGO - The Female Health Company on Monday announced that it has successfully completed a transformational merger with Aspen Park Pharmaceuticals under modified terms. The combined company brings together FHC’s existing FC2 Female Condom product with APP’s extensive drug development portfolio of products.

    The combined company will be organized as follows: Veru Healthcare will manage the Pharmaceuticals and Medical Devices and Consumer Health divisions and The Female Health Company will manage the global Public Health sector FC2 business.

  • Aralez completes acquisition of U.S. rights to Toprol-XL, authorized generic
    MISSISSAUGA, Ontario — Specialty pharmacy company Aralez Pharmaceuticals on Monday announced the completion of its acquisition of the U.S. rights to AstraZeneca’s extended-release beta blocker, Toprol-XL (metoprolol succinate) and its authorized generic. Aralez paid $175 million at closing. 
     
X
This ad will auto-close in 10 seconds